LEGN vs ZTS: fair value comparison
Legend Biotech Corporation and Zoetis Inc. · Updated 2026-10-19
LEGN's estimate rests on a sector-average multiple, which TickrTrends does not publish as a verdict. Within Healthcare, ZTS currently ranks higher by quality score. ZTS carries the stronger quality grade.
| LEGN | ZTS | |
|---|---|---|
| Verdict | Awaiting full valuation | Undervalued |
| Last price | $18.48 | $74.81 |
| 12-month range | $16.65–$36.28 | $69.10–$147.53 |
| Rank by discount to fair value | — | #98 of 108 Healthcare |
| Rank by quality score | #85 of 301 Healthcare | #83 of 301 Healthcare |
| Quality grade | C | B |
| Leverage | Low | High |
| Margin trend | Contracting | Stable |
| Revenue growth | High | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | — |
| DCF cross-check | — | Fairly Valued |
| 52-week position | The bottom quarter | The bottom quarter |
Full single-stock breakdowns: LEGN fair value analysis · ZTS fair value analysis